Variant report
Variant | nsv822828 |
---|---|
Chromosome Location | chr4:171947856-171949040 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190137318 | chr4:171947877-171947878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530892068 | chr4:171947883-171947884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551015340 | chr4:171947929-171947930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570887383 | chr4:171947942-171947943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533252343 | chr4:171947964-171947965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528301134 | chr4:171948021-171948022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2877579 | chr4:171948042-171948043 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs533539326 | chr4:171948044-171948045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566949331 | chr4:171948051-171948052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35179546 | chr4:171948059-171948060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148183862 | chr4:171948077-171948078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141586183 | chr4:171948105-171948106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536623952 | chr4:171948165-171948166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185830200 | chr4:171948282-171948283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576809493 | chr4:171948322-171948323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75922469 | chr4:171948370-171948371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376934789 | chr4:171948371-171948372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553034717 | chr4:171948447-171948448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs77372679 | chr4:171948497-171948498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567178742 | chr4:171948534-171948535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542060626 | chr4:171948558-171948559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189756007 | chr4:171948577-171948578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182757579 | chr4:171948597-171948598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536240876 | chr4:171948647-171948648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371405892 | chr4:171948649-171948650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564465240 | chr4:171948651-171948652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75431533 | chr4:171948715-171948716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528608529 | chr4:171948772-171948773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189017439 | chr4:171948797-171948798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs193104075 | chr4:171948799-171948800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183467531 | chr4:171948810-171948811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369949358 | chr4:171948855-171948856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187444660 | chr4:171948865-171948866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35634213 | chr4:171948866-171948867 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs538136085 | chr4:171948914-171948915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551701998 | chr4:171948935-171948936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545220114 | chr4:171948964-171948965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Developmental delay | 22127048 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:171944600-171949000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:171945200-171948000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
3 | chr4:171945400-171948200 | Enhancers | Primary hematopoietic stem cells | blood |
4 | chr4:171946200-171949000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:171946400-171949200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr4:171946400-171950200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr4:171946400-171954800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr4:171947200-171949200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr4:171947400-171949200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr4:171947400-171949600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr4:171947400-171949600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr4:171948000-171949400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
13 | chr4:171949000-171949800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr4:171949000-171949800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |